exeporfinium chloride (XF-73) / Cystic Fibrosis Foundation, Destiny Pharma  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
exeporfinium chloride (XF-73) / Destiny Pharma
NCT01592214: Study of the Safety and Local Tolerability of Intranasal Gel Formulations of XF-73

Completed
1
48
US
Placebo, XF-73 in 2% Klucel gel, XF-73 in 4% Klucel gel
National Institute of Allergy and Infectious Diseases (NIAID)
Staphylococcal Infection
08/15
08/15

Download Options